deoxyglucose has been researched along with azd 6244 in 1 studies
| Studies (deoxyglucose) | Trials (deoxyglucose) | Recent Studies (post-2010) (deoxyglucose) | Studies (azd 6244) | Trials (azd 6244) | Recent Studies (post-2010) (azd 6244) |
|---|---|---|---|---|---|
| 11,426 | 171 | 1,375 | 477 | 80 | 423 |
| Protein | Taxonomy | deoxyglucose (IC50) | azd 6244 (IC50) |
|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.014 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.4845 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arunan, V; Beloueche-Babari, M; Eykyn, TR; Falck Miniotis, M; Leach, MO; Marais, R; Workman, P | 1 |
1 other study(ies) available for deoxyglucose and azd 6244
| Article | Year |
|---|---|
MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzimidazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Diphenylamine; Female; Gene Knockdown Techniques; Glucose; Hexokinase; Humans; Lactic Acid; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Melanoma; Mice; Mutation, Missense; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |